A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 715
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LTBI
Long Form : latent TB infection
No. Year Title Co-occurring Abbreviation
2021 "If I've got latent TB, I would like to get rid of it": Derivation of the CARD (Constraints, Actions, Risks, and Desires) Framework informed by South African healthcare worker perspectives on latent tuberculosis treatment. CARD, HWs, TB
2021 A multidrug-resistant tuberculosis outbreak in a language school: Tokyo, Japan, 2019-2020. CI, MDR, TB
2021 Achieving a "step change" in the tuberculosis epidemic through comprehensive community-wide intervention: a model-based analysis. TB
2021 Active screening for tuberculosis in high-incidence Inuit communities in Canada: a cost-effectiveness analysis. TB
2021 An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study. CI, TB
2021 An outbreak of pulmonary tuberculosis and a follow-up investigation of latent tuberculosis in a high school in an eastern city in China, 2016-2019. CI, MIRU-VNTR, RR, TB, TST
2021 An Update on Tuberculosis Vaccines. Mtb, PoD, POI, PoR, rBCG, TB
2021 Antibody Subclass and Glycosylation Shift Following Effective TB Treatment. ATB, Mtb, TB
2021 Aptamer Detection of Mycobaterium tuberculosis Mannose-Capped Lipoarabinomannan in Lesion Tissues for Tuberculosis Diagnosis. AFS, EPTB, IGRA, IHC, ManLAM, Mtb, PTB, TB
10  2021 Assessment of Interferon Gamma-Induced Protein 10 mRNA Release Assay for Detection of Latent Tuberculosis Infection in Egyptian Pediatric Household Contacts. PHC, QFN-G-IT, RT-qPCR, TB, TST
11  2021 CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries. TB
12  2021 Challenges in LTBI care in the United States identified using a nationwide TB medical consultation database. CDC, COEs, HCPs
13  2021 Clinical Characteristics and Risk Factors of Early-Onset Tuberculosis After Liver Transplantation. LT, TB
14  2021 Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2. Mtb, TB
15  2021 Collaborative tuberculosis/HIV activities in the European Region. PLHIV, TB
16  2021 Combination of HLA-DR on Mycobacterium tuberculosis-Specific Cells and Tuberculosis Antigen/Phytohemagglutinin Ratio for Discriminating Active Tuberculosis From Latent Tuberculosis Infection. ATB, AUC, Mtb, ROC, TB
17  2021 Combined analysis of whole blood interferon gamma release assay and complete blood count analysis for rapid discrimination of active tuberculosis and latent tuberculosis infection. CBC, Hb, IFN-gamma, Mtb, ROC, TB, TST, WHO
18  2021 Comparing tuberculosis gene signatures in malnourished individuals using the TBSignatureProfiler. BMI, TB
19  2021 Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study. QFT-GIT, QFT-Plus, TB
20  2021 Completion Rate and Safety of Programmatic Screening and Treatment for Latent Tuberculosis Infection in Elderly Patients With Poorly Controlled Diabetic Mellitus: A Prospective Multicenter Study. DM, pDM, QFT, TB
21  2021 Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis. COVID-19, CST, Mtb, SARS-CoV-2, TB, US-CDC
22  2021 CXCL1: A new diagnostic biomarker for human tuberculosis discovered using Diversity Outbred mice. ATB, DO, TB
23  2021 Defining the Role of Cellular Immune Signatures in Diagnostic Evaluation of Suspected Tuberculosis. AFB, IGRA, Mtb, TB
24  2021 Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy. ATB, TB, TST
25  2021 Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease. ATB, IFN
26  2021 Effect of a Nurse-Led Community Health Worker Intervention on Latent Tuberculosis Medication Completion Among Homeless Adults. 3HP, TB
27  2021 Epidemiology and Prevention of Tuberculosis and Chronic Hepatitis B Virus Infection in the United States. CHB, TB, US
28  2021 Estimating the Incidence of Tuberculosis - Shanghai, China, 2025-2050. RR-TB, TB
29  2021 Evaluation of point-of-care algorithms to detect diabetes during screening for latent TB infection. DM, HbA1c, POC, RBG
30  2021 Evaluation of role of interferon gamma release assays in the diagnosis of latent tuberculosis in human immunodeficiency virus-infected patients. HIV, IGRAs, MDR, TB, TST
31  2021 Experiences with latent TB cascade of care strengthening for household contacts in Calgary, Canada. TST
32  2021 Factors associated with latent tuberculosis among international migrants in Brazil: a cross-sectional study (2020). TST
33  2021 Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis. ART, PLWH, TPT
34  2021 Guidelines on controlling latent tuberculosis infection to support tuberculosis elimination. TST
35  2021 Heme oxygenase-1 and neopterin plasma/serum levels and their role in diagnosing active and latent TB among HIV/TB co-infected patients: a cross sectional study. ATB, ATB, AUC, COHSONET, HO-1, KDRS, TB, TST
36  2021 Identification of Mycobacterium tuberculosis Antigens with Vaccine Potential Using a Machine Learning-Based Reverse Vaccinology Approach. Mtb, pag, TB
37  2021 Identifying factors affecting latent tuberculosis treatment acceptance among healthcare workers: a retrospective analysis in a tertiary care centre. HCWs, TB, TST
38  2021 IgG4-Related Disease With Tuberculosis: A Case Report and Retrospective Review of Patients in a Single Center. IFN-gamma, IgG4-RD, MRI, TB, TST
39  2021 ILC2s induce adaptive Th2-type immunity in different stages of tuberculosis through the Notch-GATA3 pathway. ATB, RTB, TB
40  2021 Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infection. BAL, Mtb
41  2021 Impact of Positive Interferon-Gamma Release Assay on IVF-ET Pregnancy Outcomes in Infertile Patients With Untreated Prior Tuberculosis: A Prospective Cohort Study. CXR, IGRA, PTB, TB
42  2021 Infectious Diseases Learning Unit: Understanding Advances in the Treatment of Latent Tuberculosis Infection Among People With Human Immunodeficiency Virus. ART, PWH, TB, TPT
43  2021 Interferon Gamma Release Assay and Tuberculin Skin Test Performance in Pregnant Women Living With and Without HIV. QFT-Plus, TST, WLHIV
44  2021 Interferon-gamma release assays for latent tuberculosis infection screening in Canadian federal correctional facilities. IGRA, QFT-GIT, TST
45  2021 Latent TB Infection in USSOF: A Refresher and Update. CDC, TB, USSOF
46  2021 Latent tuberculosis infection among contacts of patients with multidrug-resistant tuberculosis in New South Wales, Australia. MDR, TB
47  2021 Latent tuberculosis infection among patients with and without type-2 diabetes mellitus: results from a hospital case-control study in Atlanta. T2DM
48  2021 Latent Tuberculosis Infection and Subclinical Coronary Atherosclerosis in Peru and Uganda. ASCVD, CAD-RADS, QFT, TB
49  2021 Less Common Respiratory Conditions: Pulmonary Tuberculosis. IGRA, TB, TSTs
50  2021 Lymphocyte Non-Specific Function Detection Facilitating the Stratification of Mycobacterium tuberculosis Infection. ATB, AUC, CFP-10, PHA, TB, TBAg
51  2021 Management of childhood and adolescent latent tuberculous infection (LTBI) in Germany, Austria and Switzerland. IGRA, TB, TST
52  2021 Modelling the Cost-Effectiveness of Latent Tuberculosis Screening and Treatment Strategies in Recent Migrants to a Low Incidence Setting. QALY, TB
53  2021 Monocyte metabolic transcriptional programs associate with resistance to tuberculin skin test/interferon-gamma release assay conversion. AMPK, FFA, IGRA, Mtb, OA, PA, TST
54  2021 Monocyte-related gene biomarkers for latent and active tuberculosis. CIBERSORT, DAVID, DEMonRGs, GEO, PBMCs, TB
55  2021 Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring. ATB, HD, ROC-AUC
56  2021 Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas. ATB, BAL, IL-10, iNOS, MDSCs, MMP-9, NHP, NHPs, PD-L1, PMN-MDSCs, TB
57  2021 Opportunities for overcoming tuberculosis: Emerging targets and their inhibitors. Mtb, TB
58  2021 Performance of an Advanced Interferon-Gamma Release Assay for Mycobacterium tuberculosis Detection. CLIA, IFN-gamma, QFT-Plus, TB
59  2021 Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb-Infected Adults. Mtb, TB
60  2021 Phenotype of Peripheral NK Cells in Latent, Active, and Meningeal Tuberculosis. ELISA, Mtb, NK, PTB, TB, TBM
61  2021 PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease. BCG, HD, MDSC, Mtb, PMN, ROC, TB
62  2021 Predicting the impact of control strategies on the tuberculosis burden in South and North Korea using a mathematical model. DS-TB, MDR-TB, TB
63  2021 Prevalence and Risk Factors of Latent Tuberculosis Infection (LTBI) in Patients with Type 2 Diabetes Mellitus (T2DM). aOR, CIs, T2DM, TB
64  2021 Prevalence of latent tuberculosis infection and feasibility of TB preventive therapy among Thai prisoners: a cross-sectional study. IPT, QFTP, TST
65  2021 Protein and Microbial Biomarkers in Sputum Discern Acute and Latent Tuberculosis in Investigation of Pastoral Ethiopian Cohort. Mtb, NCC, TB
66  2021 Revisiting tuberculosis screening: An insight to complementary diagnosis and prospective molecular approaches for the recognition of the dormant TB infection in human and cattle hosts. boLTBI, IGRA, TB, TST
67  2021 Risk of active tuberculosis in migrants diagnosed with cancer: a retrospective cohort study in British Columbia, Canada. BC, TB
68  2021 Screening for active and latent TB among migrants in France. ---
69  2021 Screening for Mycobacterium tuberculosis Infection Using Beijing/K Strain-Specific Peptides in a School Outbreak Cohort. IGRA, Mtb
70  2021 Self-reported Engagement in Care among U.S. Residents with Latent Tuberculosis Infection: 2011-2012. TB
71  2021 Seven-year retrospective study understanding the latent TB infection treatment cascade of care among adults in a low incidence country. aRR
72  2021 State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity. CI, TB
73  2021 Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis. ICERs, IGRA, QALYs, TB, TPT
74  2021 TB contact tracing for young children: an Australian cascade of care review. TPT, TST
75  2021 The effectiveness of contact investigation among contacts of tuberculosis patients: a systematic review and meta-analysis. TB
76  2021 The emerging role of exosomal miRNAs as a diagnostic and therapeutic biomarker in Mycobacterium tuberculosis infection. Mtb, TB
77  2021 The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report. CFU, MDSCs, TB
78  2021 The knowns and unknowns of latent Mycobacterium tuberculosis infection. Mtb, TB
79  2021 Transcriptomic Biomarkers for Tuberculosis: Validation of NPC2 as a Single mRNA Biomarker to Diagnose TB, Predict Disease Progression, and Monitor Treatment Response. AUROC
80  2021 Tuberculosis contact investigation following the stone-in-the-pond principle in the Netherlands - Did adjusted guidelines improve efficiency? CI, TB
81  2021 Upregulation of PD-1 expression on circulating CD8+ but not CD4+ T cells is associated with tuberculosis infection in health care workers. HCWs, QFT-GIT, TB, TN, TTM
82  2021 [Isoniazid-inducedtoxic hepatitis]. ---
83  2020 A blood RNA transcript signature for TB exposure in household contacts. IGRA
84  2020 A cost-effectiveness study of tuberculosis and latent tuberculosis infection screening in prisons in Japan. CXR, IGRA, TB
85  2020 A model for bringing TB expertise to HIV providers: Medical consultations to the CDC-funded Regional Tuberculosis Training and Medical Consultation Centers, 2013-2017. ART, CDC, HIV, MCD, RTMCCs, TB
86  2020 A public health approach to increase treatment of latent TB among household contacts in Brazil. HHCs
87  2020 A transcriptional blood signature distinguishes early tuberculosis disease from latent tuberculosis infection and uninfected individuals in a Vietnamese cohort. TB
88  2020 A tuberculin skin test survey among healthcare workers in two public tertiary care hospitals in Bangladesh. HCWs, TST
89  2020 A tuberculosis outbreak in a psychiatric hospital: Kanagawa, Japan, 2012. CI, IGRA, TB
90  2020 Accuracy of QuantiFERON-TB Gold Plus Test for Diagnosis of Mycobacterium tuberculosis Infection in Children. QFT-IT, QFT-Plus, TB
91  2020 An RNA-seq Based Machine Learning Approach Identifies Latent Tuberculosis Patients With an Active Tuberculosis Profile. TB
92  2020 Anti-inflammatory cytokines IL-27, IL-10, IL-1Ra and TGF-β in subjects with increasing grades of glucose intolerence (DM-LTB-2). NGT
93  2020 Antigens of Mycobacterium tuberculosis Stimulate CXCR6+ Natural Killer Cells. ATB, CW, CXCR6, HD, Mtb, NK
94  2020 BCG Vaccine Protection against TB Infection among Children Older than 5 Years in Close Contact with an Infectious Adult TB Case. BCG, QFT-GIT, TB
95  2020 Blood M2a monocyte polarization and increased formyl peptide receptor 1 expression are associated with progression from latent tuberculosis infection to active pulmonary tuberculosis disease. FPR, Mtb, NIHS
96  2020 CD4 T Cells in Mycobacterium tuberculosis and Schistosoma mansoni Co-infected Individuals Maintain Functional TH1 Responses. HC, Mtb, Sm, TB
97  2020 Comparison of Latent Tuberculosis Infections among General versus Tuberculosis Health Care Workers in Myanmar. HCWs, TB, TST
98  2020 Comparison of QFT-Plus and QFT-GIT tests for diagnosis of M. tuberculosis infection in immunocompetent Korean subjects. QFT-GIT, TB
99  2020 Comparison of QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube, and T-SPOT.TB among patients with tuberculosis. IFN, QFT-GIT, QFT-Plus, TB
100  2020 Cost effectiveness of testing HIV infected individuals for TB in a low TB/HIV setting. ART, IGRA, TST